Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03497936 · ClinicalTrials.gov registry record · NA
Marketability of a Technology-based Intervention to Increase HPV Vaccination
A NA study, sponsored by Real Prevention.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT03497936 is a NA study that has completed, run by Real Prevention. The registered enrollment target is 360 participants.
The verdict
NCT03497936, a NA study, has completed, sponsored by Real Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
The overall goal of this SBIR Phase II project is to reduce cancer rates by marketing a brief, easily implemented technology-based intervention that increases human papillomavirus (HPV) vaccination among Planned Parenthood and other clients. The intervention's innovative technology allows for the investigators' narrative videos to be presented along will reminder texts. It will be evaluated for use in waiting rooms and promises to overcome vaccination barriers among high risk but underserved low SES and minority populations.
Interventions
- BEHAVIORAL Women's Stories
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2021-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03497936
The ClinicalTrials.gov registry entry for NCT03497936 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Real Prevention, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Women's Stories is the first listed.
NCT03497936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03497936 about?
NCT03497936 is a clinical study titled "Marketability of a Technology-based Intervention to Increase HPV Vaccination". The overall goal of this SBIR Phase II project is to reduce cancer rates by marketing a brief, easily implemented technology-based intervention that increases human papillomavirus (HPV) vaccination among Planned Parenthood and other clients. The intervention's innovative technology allows for the in...
What is the current status of trial NCT03497936?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2018-05-01. Estimated completion is 2021-03-29.
What interventions are being tested in trial NCT03497936?
The interventions under investigation include: Women's Stories (BEHAVIORAL).
Who is sponsoring clinical trial NCT03497936?
This trial is sponsored by Real Prevention, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.